Cargando…

Serum connective tissue growth factor is a highly discriminatory biomarker for the diagnosis of rheumatoid arthritis

BACKGROUND: Our previous proteomic study indicated that connective tissue growth factor (CTGF) may be a potential biomarker for rheumatoid arthritis (RA) diagnosis. The aim was to assess the performance of CTGF as a biomarker of RA. METHOD: Serum and synovial fluid CTGF was detected using a direct h...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xinyu, Lin, Ke, Ni, Shanmin, Wang, Jianmin, Tian, Qingqing, Chen, Huaijun, Brown, Matthew A., Zheng, Kaidi, Zhai, Weitao, Sun, Li, Jin, Shengwei, Wang, Jianguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700625/
https://www.ncbi.nlm.nih.gov/pubmed/29166915
http://dx.doi.org/10.1186/s13075-017-1463-1
_version_ 1783281162604511232
author Yang, Xinyu
Lin, Ke
Ni, Shanmin
Wang, Jianmin
Tian, Qingqing
Chen, Huaijun
Brown, Matthew A.
Zheng, Kaidi
Zhai, Weitao
Sun, Li
Jin, Shengwei
Wang, Jianguang
author_facet Yang, Xinyu
Lin, Ke
Ni, Shanmin
Wang, Jianmin
Tian, Qingqing
Chen, Huaijun
Brown, Matthew A.
Zheng, Kaidi
Zhai, Weitao
Sun, Li
Jin, Shengwei
Wang, Jianguang
author_sort Yang, Xinyu
collection PubMed
description BACKGROUND: Our previous proteomic study indicated that connective tissue growth factor (CTGF) may be a potential biomarker for rheumatoid arthritis (RA) diagnosis. The aim was to assess the performance of CTGF as a biomarker of RA. METHOD: Serum and synovial fluid CTGF was detected using a direct high sensitivity sandwich ELISA kit. Serum CTGF levels were tested for discriminatory capacity and optimal assay cutoffs determined in a training cohort of 98 cases of RA with 103 healthy controls. The assay performance was then validated in a further cohort of 572 patients (with RA (n = 217), ankylosing spondylitis (n = 92), gout (n = 74), osteoarthritis (n = 52), systemic lupus erythematosus (n = 72), or primary Sjögren’s syndrome (pSS) (n = 65)). RESULTS: Significant elevation of synovial fluid CTGF concentration was found in RA patients, demonstrating excellent diagnostic ability to predict RA (area under the curve (AUC) = 0.97). Similar results were found in serum CTGF detection. At the optimal cutoff value 88.66 pg/mL, the sensitivity, specificity, and the AUC was 0.86, 0.92, and 0.92, respectively, in the training cohort. Similar performance was observed in the validation cohort, with sensitivity, specificity, positive likelihood, and negative likelihood of 0.82, 0.91, 5.74, and 0.12, respectively. Stronger discriminatory capacity was seen with the combination of CTGF and anti-citrullinated protein antibody (ACPA) (AUC = 0.96) than with either ACPA or rheumatoid factor (RF) alone (AUC = 0.80 or 0.79, respectively). The discriminatory performance of serum CTGF was consistent across all inflammatory conditions tested (AUC >0.92 in all cases), with the sole exception of pSS. Serum CTGF did not vary with symptom duration or disease activity. CONCLUSIONS: Serum CTGF is a promising diagnostic biomarker for RA, with performance in the current study better than either ACPA or RF. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13075-017-1463-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5700625
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-57006252017-12-01 Serum connective tissue growth factor is a highly discriminatory biomarker for the diagnosis of rheumatoid arthritis Yang, Xinyu Lin, Ke Ni, Shanmin Wang, Jianmin Tian, Qingqing Chen, Huaijun Brown, Matthew A. Zheng, Kaidi Zhai, Weitao Sun, Li Jin, Shengwei Wang, Jianguang Arthritis Res Ther Research Article BACKGROUND: Our previous proteomic study indicated that connective tissue growth factor (CTGF) may be a potential biomarker for rheumatoid arthritis (RA) diagnosis. The aim was to assess the performance of CTGF as a biomarker of RA. METHOD: Serum and synovial fluid CTGF was detected using a direct high sensitivity sandwich ELISA kit. Serum CTGF levels were tested for discriminatory capacity and optimal assay cutoffs determined in a training cohort of 98 cases of RA with 103 healthy controls. The assay performance was then validated in a further cohort of 572 patients (with RA (n = 217), ankylosing spondylitis (n = 92), gout (n = 74), osteoarthritis (n = 52), systemic lupus erythematosus (n = 72), or primary Sjögren’s syndrome (pSS) (n = 65)). RESULTS: Significant elevation of synovial fluid CTGF concentration was found in RA patients, demonstrating excellent diagnostic ability to predict RA (area under the curve (AUC) = 0.97). Similar results were found in serum CTGF detection. At the optimal cutoff value 88.66 pg/mL, the sensitivity, specificity, and the AUC was 0.86, 0.92, and 0.92, respectively, in the training cohort. Similar performance was observed in the validation cohort, with sensitivity, specificity, positive likelihood, and negative likelihood of 0.82, 0.91, 5.74, and 0.12, respectively. Stronger discriminatory capacity was seen with the combination of CTGF and anti-citrullinated protein antibody (ACPA) (AUC = 0.96) than with either ACPA or rheumatoid factor (RF) alone (AUC = 0.80 or 0.79, respectively). The discriminatory performance of serum CTGF was consistent across all inflammatory conditions tested (AUC >0.92 in all cases), with the sole exception of pSS. Serum CTGF did not vary with symptom duration or disease activity. CONCLUSIONS: Serum CTGF is a promising diagnostic biomarker for RA, with performance in the current study better than either ACPA or RF. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13075-017-1463-1) contains supplementary material, which is available to authorized users. BioMed Central 2017-11-22 2017 /pmc/articles/PMC5700625/ /pubmed/29166915 http://dx.doi.org/10.1186/s13075-017-1463-1 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Yang, Xinyu
Lin, Ke
Ni, Shanmin
Wang, Jianmin
Tian, Qingqing
Chen, Huaijun
Brown, Matthew A.
Zheng, Kaidi
Zhai, Weitao
Sun, Li
Jin, Shengwei
Wang, Jianguang
Serum connective tissue growth factor is a highly discriminatory biomarker for the diagnosis of rheumatoid arthritis
title Serum connective tissue growth factor is a highly discriminatory biomarker for the diagnosis of rheumatoid arthritis
title_full Serum connective tissue growth factor is a highly discriminatory biomarker for the diagnosis of rheumatoid arthritis
title_fullStr Serum connective tissue growth factor is a highly discriminatory biomarker for the diagnosis of rheumatoid arthritis
title_full_unstemmed Serum connective tissue growth factor is a highly discriminatory biomarker for the diagnosis of rheumatoid arthritis
title_short Serum connective tissue growth factor is a highly discriminatory biomarker for the diagnosis of rheumatoid arthritis
title_sort serum connective tissue growth factor is a highly discriminatory biomarker for the diagnosis of rheumatoid arthritis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700625/
https://www.ncbi.nlm.nih.gov/pubmed/29166915
http://dx.doi.org/10.1186/s13075-017-1463-1
work_keys_str_mv AT yangxinyu serumconnectivetissuegrowthfactorisahighlydiscriminatorybiomarkerforthediagnosisofrheumatoidarthritis
AT linke serumconnectivetissuegrowthfactorisahighlydiscriminatorybiomarkerforthediagnosisofrheumatoidarthritis
AT nishanmin serumconnectivetissuegrowthfactorisahighlydiscriminatorybiomarkerforthediagnosisofrheumatoidarthritis
AT wangjianmin serumconnectivetissuegrowthfactorisahighlydiscriminatorybiomarkerforthediagnosisofrheumatoidarthritis
AT tianqingqing serumconnectivetissuegrowthfactorisahighlydiscriminatorybiomarkerforthediagnosisofrheumatoidarthritis
AT chenhuaijun serumconnectivetissuegrowthfactorisahighlydiscriminatorybiomarkerforthediagnosisofrheumatoidarthritis
AT brownmatthewa serumconnectivetissuegrowthfactorisahighlydiscriminatorybiomarkerforthediagnosisofrheumatoidarthritis
AT zhengkaidi serumconnectivetissuegrowthfactorisahighlydiscriminatorybiomarkerforthediagnosisofrheumatoidarthritis
AT zhaiweitao serumconnectivetissuegrowthfactorisahighlydiscriminatorybiomarkerforthediagnosisofrheumatoidarthritis
AT sunli serumconnectivetissuegrowthfactorisahighlydiscriminatorybiomarkerforthediagnosisofrheumatoidarthritis
AT jinshengwei serumconnectivetissuegrowthfactorisahighlydiscriminatorybiomarkerforthediagnosisofrheumatoidarthritis
AT wangjianguang serumconnectivetissuegrowthfactorisahighlydiscriminatorybiomarkerforthediagnosisofrheumatoidarthritis